NO178397C - Substituerte 1,2,3,4-tetrahydrocyklopent[bÅindoler, 1,2,3,3a,4,8a-heksahydrocyklopent[bÅindoler og beslektede forbindelser, mellomprodukter og deres bruk som medikamenter - Google Patents

Substituerte 1,2,3,4-tetrahydrocyklopent[bÅindoler, 1,2,3,3a,4,8a-heksahydrocyklopent[bÅindoler og beslektede forbindelser, mellomprodukter og deres bruk som medikamenter

Info

Publication number
NO178397C
NO178397C NO920235A NO920235A NO178397C NO 178397 C NO178397 C NO 178397C NO 920235 A NO920235 A NO 920235A NO 920235 A NO920235 A NO 920235A NO 178397 C NO178397 C NO 178397C
Authority
NO
Norway
Prior art keywords
indole
intermediates
tetrahydrocyclopentic
hexahydrocyclopentic
drugs
Prior art date
Application number
NO920235A
Other languages
English (en)
Norwegian (no)
Other versions
NO178397B (no
NO920235L (no
NO920235D0 (no
Inventor
Helen Hu Ong
Gerard Joseph O'malley
Michael Clayton Merriman
Mark Gabriel Palermo
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NO920235D0 publication Critical patent/NO920235D0/no
Publication of NO920235L publication Critical patent/NO920235L/no
Publication of NO178397B publication Critical patent/NO178397B/no
Publication of NO178397C publication Critical patent/NO178397C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO920235A 1991-01-18 1992-01-17 Substituerte 1,2,3,4-tetrahydrocyklopent[bÅindoler, 1,2,3,3a,4,8a-heksahydrocyklopent[bÅindoler og beslektede forbindelser, mellomprodukter og deres bruk som medikamenter NO178397C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/642,952 US5100891A (en) 1991-01-18 1991-01-18 Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds

Publications (4)

Publication Number Publication Date
NO920235D0 NO920235D0 (no) 1992-01-17
NO920235L NO920235L (no) 1992-07-20
NO178397B NO178397B (no) 1995-12-11
NO178397C true NO178397C (no) 1996-03-20

Family

ID=24578739

Family Applications (1)

Application Number Title Priority Date Filing Date
NO920235A NO178397C (no) 1991-01-18 1992-01-17 Substituerte 1,2,3,4-tetrahydrocyklopent[bÅindoler, 1,2,3,3a,4,8a-heksahydrocyklopent[bÅindoler og beslektede forbindelser, mellomprodukter og deres bruk som medikamenter

Country Status (26)

Country Link
US (1) US5100891A (fr)
EP (1) EP0496314B1 (fr)
JP (1) JP2665422B2 (fr)
KR (1) KR100230881B1 (fr)
AT (1) ATE158790T1 (fr)
AU (1) AU650315B2 (fr)
BR (1) BR9200171A (fr)
CA (1) CA2059610C (fr)
CZ (1) CZ282732B6 (fr)
DE (1) DE69222444T2 (fr)
DK (1) DK0496314T3 (fr)
ES (1) ES2109953T3 (fr)
FI (2) FI102174B1 (fr)
GR (1) GR3025318T3 (fr)
HU (1) HUT67027A (fr)
IE (1) IE920149A1 (fr)
IL (1) IL100693A0 (fr)
MX (1) MX9200206A (fr)
NO (1) NO178397C (fr)
NZ (1) NZ241305A (fr)
PH (1) PH31429A (fr)
PL (2) PL169417B1 (fr)
RO (1) RO112505B1 (fr)
RU (1) RU2077530C1 (fr)
TW (1) TW198024B (fr)
ZA (1) ZA92341B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298626A (en) * 1991-01-18 1994-03-29 Hoechst-Roussel Pharmaceuticals Incorporated Select cyclopent[b]indoles
US5350762A (en) * 1993-03-08 1994-09-27 Hoechst-Roussel Pharmaceuticals Incorporated Tetrahydrocyclopent[B]indole methanamines and related compounds
DE997458T1 (de) * 1997-07-03 2001-03-01 Asahi Kasei Kogyo K.K., Osaka Tricyclische verbindungen mit gesättigten ringen und diese enthaltende medizinische zubereitungen
UA69420C2 (uk) * 1998-10-06 2004-09-15 Янссен Фармацевтика Н.В. ТРИЦИКЛІЧНІ <font face="Symbol">D3</font>-ПІПЕРИДИНИ ЯК <font face="Symbol">a<sub></font>2</sub>-АНТАГОНІСТИ
UA70334C2 (en) * 1998-10-06 2004-10-15 Janssen Pharmaceutica N V Jans BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS BENZOTHIENO[3,2-c]PYRIDINES AS a2 ANTAGONISTS
SK285386B6 (sk) * 1998-10-06 2006-12-07 Janssen Pharmaceutica N. V. Tricyklické delta3-piperidíny ako farmaceutiká a spôsob ich prípravy
IT1317926B1 (it) 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Derivati triciclici dell'indolo ad attivita' antiangiogenica.
CA2528321A1 (fr) 2003-06-10 2004-12-23 Smithkline Beecham Corporation Derives de tetrahydrocarbazole et leur utilisation pharmaceutique
RU2005138126A (ru) 2003-06-12 2006-07-27 СмитКлайн Бичем Корпорейшн (US) Производные тетрагидрокарбазола и их фармацевтическое применение
US8143257B2 (en) * 2004-11-23 2012-03-27 Ptc Therapeutics, Inc. Substituted phenols as active agents inhibiting VEGF production
GB2422828A (en) * 2005-02-03 2006-08-09 Hunter Fleming Ltd Tricyclic cytoprotective compounds comprising an indole residue
WO2013139929A1 (fr) * 2012-03-22 2013-09-26 Ludwig-Maximilians-Universität München Nouveaux moyens et méthodes pour le traitement de maladies du système nerveux central, de maladies cardiaques et métaboliques et du vieillissement
KR20140013471A (ko) 2012-07-24 2014-02-05 주식회사 쎄코 진공증착용 발열조립체 및 이를 구비하는 진공증착장치
US10882821B1 (en) 2017-09-26 2021-01-05 The Board Of Trustees Of The Leland Stanford Junior University Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514462A (en) * 1966-10-21 1970-05-26 Upjohn Co 1 and 2 ethoxy 3,4,5,10 - tetrahydroazepino(3,4-b) and (2,3-b)indoles and corresponding amino derivatives thereof
US3595874A (en) * 1969-02-28 1971-07-27 Upjohn Co 3,4,5,10-tetrahydroazepino(2,3-b)indol-5a (2h)-ols
BE787537A (fr) * 1971-08-16 1973-02-14 Sterling Drug Inc Tetrahydrocarbazoles
SU482086A1 (ru) * 1973-11-30 1976-03-15 Всесоюзный Научно-Исследовательски% Химико-Фармацевтический Институт Им.С.Орджоникидзе Способ получени производных 1- -амино1,2,3,4-тетрагидрокарбазола
JPS5111760A (fr) * 1974-06-18 1976-01-30 Ayerst Mckenna & Harrison
US4254134A (en) * 1978-03-17 1981-03-03 Endo Laboratories, Inc. Antidepressant 2-amino- and -2-(substituted amino)-cis-hexahydro-carbazoles

Also Published As

Publication number Publication date
FI920192A0 (fi) 1992-01-16
FI107919B (fi) 2001-10-31
GR3025318T3 (en) 1998-02-27
NO178397B (no) 1995-12-11
RO112505B1 (ro) 1997-10-30
HUT67027A (en) 1995-01-30
EP0496314A1 (fr) 1992-07-29
FI102174B (fi) 1998-10-30
CZ282732B6 (cs) 1997-09-17
JP2665422B2 (ja) 1997-10-22
BR9200171A (pt) 1992-10-06
PH31429A (en) 1998-11-03
NO920235L (no) 1992-07-20
PL169417B1 (pl) 1996-07-31
DE69222444T2 (de) 1998-06-04
IL100693A0 (en) 1992-09-06
NZ241305A (en) 1994-10-26
DE69222444D1 (de) 1997-11-06
CA2059610C (fr) 2002-04-02
JPH04334367A (ja) 1992-11-20
AU1027992A (en) 1992-07-23
PL167465B1 (pl) 1995-09-30
DK0496314T3 (da) 1998-05-18
NO920235D0 (no) 1992-01-17
PL296651A1 (en) 1993-07-26
EP0496314B1 (fr) 1997-10-01
KR100230881B1 (ko) 1999-11-15
MX9200206A (es) 1992-08-01
RU2077530C1 (ru) 1997-04-20
FI102174B1 (fi) 1998-10-30
AU650315B2 (en) 1994-06-16
KR920014777A (ko) 1992-08-25
FI20001775A (fi) 2000-08-10
FI920192A (fi) 1992-07-19
ES2109953T3 (es) 1998-02-01
IE920149A1 (en) 1992-07-29
ZA92341B (en) 1992-09-30
CS12992A3 (en) 1992-08-12
HU9200172D0 (en) 1992-04-28
TW198024B (fr) 1993-01-11
PL293209A1 (en) 1993-04-05
US5100891A (en) 1992-03-31
CA2059610A1 (fr) 1992-07-19
ATE158790T1 (de) 1997-10-15

Similar Documents

Publication Publication Date Title
NO178397C (no) Substituerte 1,2,3,4-tetrahydrocyklopent[bÅindoler, 1,2,3,3a,4,8a-heksahydrocyklopent[bÅindoler og beslektede forbindelser, mellomprodukter og deres bruk som medikamenter
DK0669920T3 (da) Substituerede 3-(aminoalkylamino)-1,2-benzisoxazoler og beslægtede forbindelser
NO308248B1 (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat
DE69216293D1 (de) 1,4-Disubstituierte Piperidinderivate, ihre Herstellung und therapeutische Verwendung
DK0517221T3 (da) ((Arylalkylpiperidin-4-yl)-methyl)-2alfa,3,4,5-tetrahydro-1(2H)-acenaphthylen-1-oner og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
DK0535645T3 (da) Carbamatderivater af 4-amino-3-isoxazolidinoner og 3-amino-1-hydroxypyrrolidin-2-oner, fremgangsmåde til deres fremstilling samt deres anvendelse som lægemidler
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
DE69533214D1 (de) 2,3-Dihydro-1H-isoindolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Hemmer der Serotoninwiederaufnahme
BR9707004A (pt) Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento
BR0115042A (pt) Ligandos de receptores de aminoalquilpirrolidina serotonina e composições, seus usos farmacêuticos, e processos para a sua sìntese
DK0709378T3 (da) Aminoalkyloximer, en fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og mellemproduktforbindelser
DK0401779T3 (da) 4,5,5a,6-Tetrahydro-3H-isoazolo(5,4,3-kl)acridinderivater, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler